Definitive Contract HHSD200201692409C
- Not listed
- This is a firm fixed price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Hospira Worldwide LLC, a for-profit manufacturer of pharmaceuticals and medical supplies. The $1,682,440.00 contract is for the procurement of various sterile injectable drugs, antibiotics, anesthetics, and other pharmaceutical products. The contract has an ultimate completion date of September 30, 2015 and was not designated as a set-aside. Based on...
- This federal contract award was made by the Defense Logistics Agency Troop Support Medical to the prime contractor Hospira Worldwide LLC, a for-profit manufacturer of pharmaceuticals and medical supplies. The contract, valued at $116,757.96, is a delivery order for firm fixed price goods and does not have a set-aside designation. Hospira Worldwide LLC is a subsidiary of the larger pharmaceutical company Pfizer Inc. Through past prime federal contracts, Hospira and Pfizer have provided a...
- This is a federal contract award to Hospira Worldwide LLC, a for-profit manufacturer of pharmaceuticals and medical supplies, by the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian agency. The contract is an Indefinite Delivery/Indefinite Quantity (IDIQ) agreement with a ceiling value of $3,048,800.00 for the delivery of pharmaceutical and medical/surgical products over a 5-year period ending on September 28, 2018. The contract is a firm fixed-price type and does...
- This federal contract award, valued at $87,000.00, was issued by the Department of Veterans Affairs (VA) to Hospira Worldwide LLC, a for-profit manufacturer of pharmaceuticals and medical supplies. The contract is a delivery order under the General Services Administration (GSA) Pharmaceutical and Drugs Federal Supply Schedule contract (FSS-61-IB) and is for the provision of sterile injectable pharmaceuticals, including antibiotics, anesthetics, and other drug solutions. This contract does not...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a 5-year Indefinite Delivery, Indefinite Quantity (IDIQ) contract to Hospira Worldwide LLC, a for-profit manufacturer of pharmaceuticals and medical supplies. The $15,329,706.00 contract is for the delivery of various sterile injectable drugs, antibiotics, anesthetics, and other medical solutions to the agency. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation....
- This federal contract award, SPE2DX15D5017|HHSN269201500468U, was issued by the Office of the Chief Operating Officer, a civilian agency, to the prime contractor Amerisourcebergen Drug Corp. The $94,263.54 Firm Fixed Price delivery order contract is for the provision of a broad range of pharmaceutical products and medical supplies, including specialty medications, generic drugs, brand-name pharmaceuticals, medical devices, syringes, vials, and vaccines across multiple therapeutic areas. The...
- This federal contract award, with ID SPE2DX15D5017|HHSN269201600356U, was issued by the Department of Health and Human Services (HHS) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $83,074.00 firm fixed-price delivery order is not associated with a set-aside designation, indicating open competition. The contract encompasses the provision of a comprehensive range of pharmaceutical products and medical supplies,...
- This federal contract award, SPE2DX15D5017|HHSN269201600141U, was issued by the Office of the Chief Operating Officer of the Department of Health and Human Services (HHS) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $96,495.18 Firm Fixed Price Delivery Order contract, which has no set-aside designation, is for the delivery of a range of pharmaceutical products and medical supplies, including specialty medications, brand-name and...
- This federal contract award, valued at $94,974.89, was issued by the Department of Health and Human Services (HHS) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there was no set-aside designation used. The contract covers the provision of a comprehensive range of pharmaceutical products and medical supplies to support federal healthcare programs,...
- This is a federal contract award from the Office of the Chief Operating Officer, a civilian government agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $97,975.41, is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. The contract supports the supply of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and...
This is a definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency within the U.S. Department of Health and Human Services, to Hospira Worldwide LLC, a subsidiary of the pharmaceutical company Pfizer Inc. The contract, valued at $28,913,670.44, is for the delivery of pharmaceuticals and medical supplies, including sterile injectables, antibiotics, anesthetics, and other drugs and solutions. The contract does not have a set-aside designation. Hospira Worldwide LLC has a history of providing similar medical products to the Defense Logistics Agency and the Department of Health and Human Services through previous prime federal contract awards. This contract award is part of the agency's efforts to ensure the availability of critical medical supplies and pharmaceuticals to support healthcare initiatives and emergency preparedness.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00012 | Change Order | $181.5k | 9/29/21 | |
| P00011 | Funding Only Action | ($986k) | 9/28/21 | |
| P00010 | Exercise an Option | $985.7k | 9/24/21 | |
| P00009 | Supplemental Agreement for work within scope | $0 | 8/17/21 | |
| P00008 | Supplemental Agreement for work within scope | $331.0k | 4/30/21 |